Lone Pine Capital’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$673M Buy
+996,686
New +$592M 4.39% 9
2023
Q1
– Sell
-587,696
Closed -$324M – 32
2022
Q4
$324M Sell
587,696
-297,630
-34% -$158M 3.09% 14
2022
Q3
$449M Sell
885,326
-46,966
-5% -$26.3M 4.23% 10
2022
Q2
$506M Buy
932,292
+411,583
+79% +$227M 4.77% 8
2022
Q1
$308M Buy
+520,709
New +$299M 1.83% 22
2013
Q3
– Sell
-2,766,476
Closed -$234M – 64
2013
Q2
$234M Buy
+2,766,476
New +$230M 1.14% 38

Other funds holding TMO

Lone Pine Capital's TMO Position: Q3 2026 in Review

Lone Pine Capital opened a new position in Thermo Fisher Scientific (TMO) in Q3 2026: 996,686 shares worth $673M. The stake represents 4.39% of the portfolio and ranks #9 among its holdings. This is a return to the name: Lone Pine Capital previously reported a position in TMO as recently as Q4 2022.

Lone Pine Capital first reported a position in TMO in Q2 2013 and has held it in 6 quarters since. 2,790 funds tracked by Wall St. Rank hold TMO as of Q3 2026.

  • Lone Pine Capital held 996,686 shares of Thermo Fisher Scientific worth $673M as of Q3 2026.
  • Thermo Fisher Scientific was a new Lone Pine Capital position in Q3 2026.
  • Thermo Fisher Scientific made up 4.39% of Lone Pine Capital's portfolio in Q3 2026, its #9 holding.
  • Lone Pine Capital first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 6 quarters since.
  • 2,790 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2026.

Based on Lone Pine Capital's 13F filing for Q3 2026, filed 16 Nov 2026.